×
About 1,173 results

ALLMedicine™ Vitreous Hemorrhage Center

Research & Reviews  408 results

Combination of Ranibizumab and Targeted Laser Photocoagulation
https://clinicaltrials.gov/ct2/show/NCT04444492

May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...

Myelin oligodendrocyte glycoprotein antibody-associated bilateral optic neuritis with u...
https://doi.org/10.1016/j.jaapos.2022.02.007
Journal of AAPOS : the Official Publication of the Americ... Mudri J, Warne R et. al.

May 8th, 2022 - We present a case of bilateral myelin oligodendrocyte glycoprotein antibody optic neuritis (MOG-ON) with unilateral vitreous hemorrhage in a 6-year-old boy. Multidisciplinary team care, including extensive investigations and prolonged follow-up, e...

"Vitreous Hemorrhage and Long-Lasting Priapism After COVID-19 m-RNA Based Vaccine: A Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080970
European Journal of Ophthalmology; Casarini B, Bruni F et. al.

May 5th, 2022 - To report a case of possible multi-district thromboembolic event involving the eye of a patient with several cardiovascular risk factors, following a second inoculation of SARS-CoV-2 m-RNA based vaccine. A 60-year-old man presented with blurred vi...

Dexamethasone Intravitreal Implant Complications Including Vitreous Hemorrhage and Hypo...
https://doi.org/10.1097/ICB.0000000000001247
Retinal Cases & Brief Reports; Yu JJ, Adrean SD

Apr 22nd, 2022 - To describe cases of visually significant vitreous hemorrhage (VH) following dexamethasone (DEX) intravitreal implant in our practice and present two cases which required surgical intervention as well as a case of VH and hypotony following DEX imp...

see more →

Clinicaltrials.gov  23 results

Combination of Ranibizumab and Targeted Laser Photocoagulation
https://clinicaltrials.gov/ct2/show/NCT04444492

May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...

Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT05318742

Apr 8th, 2022 - Enrolled patients will be randomized into 1 of 2 possible treatment groups: Group A patients underwent endolaser PRP with a range of 200-300 shots during PPV, whereas Group B patients underwent endolaser PRP with a range of 500-600 shots during PP...

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
https://clinicaltrials.gov/ct2/show/NCT05138029

Mar 8th, 2022 - Test method: Include suitable cases of diabetic retinopathy and macular edema Inclusion criteria: a. PDR patients with severe vitreous hemorrhage who cannot collect oct images and require vitrectomy b. Type 2 diabetes, aged 18~80 years old c. Good...

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV
https://clinicaltrials.gov/ct2/show/NCT02590094

Dec 3rd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics
https://clinicaltrials.gov/ct2/show/NCT04380077

Dec 2nd, 2021 - Subjects enrolled into the study are randomized into one of the ensuing treatment cohorts: Group A patients undergo vitreous substitution with 20-30% sulfur hexafluoride (SF6) gas during PPV, whereas Group B patients undergo vitreous substitution ...

see more →

News  38 results

Patient Blinded in One Eye From Surgery Wins $1.2 Million
https://www.medscape.com/viewarticle/971155

Mar 29th, 2022 - A New York appeals court has upheld a $1.2 million verdict against an eye surgeon after his patient went blind after cataract removal and lens replacement surgery. Carola Rozon visited New York ophthalmologic surgeon Edwin Schottenstein, MD, in 20...

Weighing the Risks of Treating Floaters With Vitrectomy
https://www.medscape.com/viewarticle/947651

Mar 19th, 2021 - In most clinical practices, floaters related to a posterior vitreous detachment are a common patient concern, especially in those with advancing age. Fortunately, floaters often become less symptomatic with time, and very few patients ultimately r...

Surgery Equals Drug Treatment for Bleeding in Diabetic Retinopathy
https://www.medscape.com/viewarticle/943374

Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...

Earlier Glycemic Control May Help in Latent Autoimmune Diabetes
https://www.medscape.com/viewarticle/926273

Mar 5th, 2020 - FROM THE LANCET DIABETES & ENDOCRINOLOGY The risk for microvascular complications in adults with latent autoimmune diabetes increases the longer they have the disease, according a post hoc analysis of a large European database. However, Ernesto Ma...

Latent diabetes warrants earlier, tighter glycemic control
https://www.mdedge.com/endocrinology/article/218320/diabetes/latent-diabetes-warrants-earlier-tighter-glycemic-control
Richard Mark Kirkner

Mar 3rd, 2020 - The risk for microvascular complications in adults with latent autoimmune diabetes increases the longer they have the disease, according a post hoc analysis of a large European database. However, Ernesto Maddaloni, MD, of Sapienza University of Ro.

see more →